Geneva Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.39M | Buy |
11,408
+82
| +0.7% | +$9.98K | 0.02% | 296 |
|
|
2017
Q1 | $1.37M | Sell |
11,326
-2,030
| -15% | -$246K | 0.02% | 285 |
|
|
2016
Q4 | $1.63M | Sell |
13,356
-165
| -1% | -$20.2K | 0.03% | 236 |
|
|
2016
Q3 | $1.66M | Sell |
13,521
-30
| -0.2% | -$3.68K | 0.03% | 227 |
|
|
2016
Q2 | $1.58M | Hold |
13,551
| – | – | 0.03% | 226 |
|
|
2016
Q1 | $1.89M | Sell |
13,551
-35
| -0.3% | -$4.87K | 0.04% | 197 |
|
|
2015
Q4 | $2.59M | Sell |
13,586
-105
| -0.8% | -$20K | 0.05% | 161 |
|
|
2015
Q3 | $2.14M | Sell |
13,691
-462
| -3% | -$72.2K | 0.04% | 185 |
|
|
2015
Q2 | $2.56M | Buy |
14,153
+3,399
| +32% | +$614K | 0.05% | 180 |
|
|
2015
Q1 | $1.86M | Buy |
10,754
+361
| +3% | +$62.6K | 0.03% | 214 |
|
|
2014
Q4 | $1.92M | Buy |
10,393
+228
| +2% | +$42.2K | 0.04% | 204 |
|
|
2014
Q3 | $1.69M | Sell |
10,165
-56
| -0.5% | -$9.29K | 0.03% | 213 |
|
|
2014
Q2 | $1.6M | Buy |
10,221
+1,790
| +21% | +$280K | 0.03% | 236 |
|
|
2014
Q1 | $1.28M | Buy |
8,431
+750
| +10% | +$114K | 0.02% | 265 |
|
|
2013
Q4 | $1.02M | Sell |
7,681
-14
| -0.2% | -$1.86K | 0.02% | 255 |
|
|
2013
Q3 | $894K | Sell |
7,695
-45
| -0.6% | -$5.23K | 0.02% | 267 |
|
|
2013
Q2 | $714K | Buy |
+7,740
| New | +$714K | 0.02% | 248 |
|